CEAM6 Polyclonal Antibody

This gene encodes a protein that belongs to the carcinoembryonic antigen (CEA) family whose members are glycosyl phosphatidyl inositol (GPI) anchored cell surface glycoproteins. Members of this family play a role in cell adhesion and are widely used as tumor markers in serum immunoassay determinations of carcinoma. This gene affects the sensitivity of tumor cells to adenovirus infection. The protein encoded by this gene acts as a receptor for adherent-invasive E. coli adhesion to the surface of ileal epithelial cells in patients with Crohn's disease. This gene is clustered with genes and pseudogenes of the cell adhesion molecules subgroup of the CEA family on chromosome 19.

The CEAM6 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CEAM6 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity. With its exceptional performance, the CEAM6 Polyclonal Antibody offers researchers a valuable tool for studying the role and function of CEAM6 in different physiological and pathological processes. This antibody is suitable for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. Its versatility and robustness make it an ideal choice for both basic research and clinical investigations. The CEAM6 Polyclonal Antibody is supplied in a convenient and ready-to-use format, allowing for easy and efficient experimentation. With its superior quality and performance, this antibody is an indispensable asset for scientists and researchers in the field of molecular biology and biomedical sciences.

The CEAM6 Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of CEAM6 protein expression in various biological samples. This antibody has been extensively validated and exhibits exceptional sensitivity and specificity, making it an ideal choice for researchers in the field of cancer biology and immunology.

The CEAM6 Polyclonal Antibody is produced using state-of-the-art techniques, ensuring high purity and batch-to-batch consistency. It has been rigorously tested for cross-reactivity with other related proteins to ensure accurate and reliable results. This antibody is suitable for use in various applications, including Western blotting, immunohistochemistry, and flow cytometry.

With its superior performance characteristics, the CEAM6 Polyclonal Antibody enables researchers to confidently investigate the role of CEAM6 in cancer progression, metastasis, and immune response. Its high affinity and specificity allow for precise and accurate quantification of CEAM6 protein levels, facilitating the identification of potential therapeutic targets and biomarkers.

The CEAM6 Polyclonal Antibody is supplied in a convenient and user-friendly format, ensuring ease of use and storage. It is provided in a liquid form, ready for immediate use, eliminating the need for time-consuming reconstitution. The antibody is also available in various sizes to accommodate different experimental needs.

In summary, the CEAM6 Polyclonal Antibody is a reliable and versatile tool for the detection and analysis of CEAM6 protein expression. Its exceptional sensitivity, specificity, and ease of use make it an invaluable asset for researchers in the field of cancer biology and immunology.